Logistics & Transportation
IoT Cold-Chain Monitoring for Pharmaceuticals
Published by IOT New Jersey Research & Editorial Team

- Temperature Classes Drive Everything
- Why Refrigerated Products Fail in Two Directions
- Choosing Monitoring Devices
- Single-Use and Reusable Data Loggers
- Real-Time Trackers
- Fixed Sensors in Facilities and Vehicles
- Qualified Packaging
- Judging an Excursion
- Regulations and Standards in Plain Terms
- Where New Jersey Handoffs Create Risk
- Alert Design That People Respond To
- A Composite Example
- Cell and Gene Therapy: A Different Kind of Cold Chain
- Last Mile: Hospitals, Clinics, and Pharmacies
- Cost and Return
- Data Sharing Between Partners
- Metrics to Track
- Common Mistakes
A vial of a biologic drug can be worth more than the truck that carries it. A single temperature excursion on the way to a clinic, hospital, or specialty pharmacy can compromise it, and the problem is often invisible: the product looks the same, but its stability is in question. Pharmaceutical cold chain monitoring exists to turn that invisible risk into a record and, increasingly, into a real-time alert that lets someone act before product is lost. New Jersey sits at the center of this work. Its pharmaceutical manufacturers, third-party logistics providers, airport cargo operations, and port connect to hospitals and pharmacies across the Northeast. This article focuses on the pharmaceutical specifics of cold chain monitoring: temperature classes, what devices to choose, how to judge an excursion, and how to build a program that stands up to inspection. For the general cold chain picture, see how New Jersey cold chains become more connected.
Temperature Classes Drive Everything
| Class | Typical Range | Examples | Monitoring Emphasis |
|---|---|---|---|
| Controlled room temperature | 20 to 25 degrees Celsius, with permitted excursions between 15 and 30 | Many tablets, capsules, and some injectables | Heat exposure on summer trucks and docks |
| Refrigerated | 2 to 8 degrees Celsius | Vaccines, insulin, many biologics | Both overheating and accidental freezing |
| Frozen | Around minus 20 degrees Celsius | Certain vaccines and biologics | Thawing during handoffs and delays |
| Ultra-cold and cryogenic | Around minus 70 degrees Celsius and below | Some vaccines, cell and gene therapies | Dry ice or liquid nitrogen depletion, chain of identity |
The product's label and stability data define the limits, not general rules. Always begin with what the manufacturer has qualified.
Why Refrigerated Products Fail in Two Directions
Many people think of the cold chain as protecting against heat. For products labeled for 2 to 8 degrees Celsius, freezing is just as dangerous. Some vaccines and biologics lose potency when frozen, and the damage may not be visible. Shippers placed too close to coolant packs, cold winter docks, and over-aggressive refrigeration can all push product below range. A monitoring program that alerts only for high temperatures misses half the risk. Set both upper and lower limits, and check that shipper design and winter conditions have been tested, a particular concern in New Jersey's cold months.
Choosing Monitoring Devices
Single-Use and Reusable Data Loggers
Loggers record temperature through the journey and are read at the destination. They are inexpensive and widely accepted, but they tell you what went wrong only after the shipment arrives. For lower-risk products and short, stable routes, that may be enough.
Real-Time Trackers
Cellular or satellite trackers report temperature, location, and sometimes light, shock, and door opening during the journey. They enable intervention in transit: rerouting, replacing coolant, or notifying a receiver to prepare. They cost more and need power and network coverage planning, and their value is greatest for high-value, time-sensitive, or fragile products.
Fixed Sensors in Facilities and Vehicles
Warehouses, cold rooms, refrigerated trucks, and pharmacy refrigerators all need fixed monitoring with alarms and records. Many excursions occur not on the road but at transfer points, such as a pallet left on an unrefrigerated dock. Facility sensors, as discussed in IoT environmental monitoring for pharmaceutical facilities, close that gap.
Qualified Packaging
Passive shippers with insulation and coolant, and active containers with refrigeration, have rated durations under defined conditions. Monitoring complements them, but does not replace qualification of the packaging for the lanes and seasons in use. Place sensors where they represent product conditions, normally near the product and away from direct contact with coolant.
Judging an Excursion
When a reading goes outside range, the question is whether the product is still usable. The answer depends on how far out, how long, and how sensitive the product is. For products with stability data supporting temporary excursions, evaluation can use the manufacturer's information. For room temperature products, USP general chapter 1079.2, published in 2023, discusses the use of mean kinetic temperature, a way of expressing the cumulative thermal effect of variable temperatures during storage and transport. Never decide on a rule of thumb. Contact the manufacturer's medical or technical information line, document the decision, and quarantine product until the evaluation is complete. Quality teams should confirm the current approach for each product.
Regulations and Standards in Plain Terms
Distributors and manufacturers work under good distribution practice expectations that require control of storage and transport conditions, qualified equipment, calibrated instruments, documented procedures, and investigation of deviations. European good distribution practice guidelines are widely used as a reference, and USP offers general chapters on storage and distribution. In the United States, the Drug Supply Chain Security Act adds traceability requirements for product moving between trading partners, and cold chain data often travels in the same systems. Requirements and deadlines change, so confirm what applies to your role in the supply chain. The data integrity expectations are the same as for plant records: time-stamped, attributable, protected, and retrievable.
Where New Jersey Handoffs Create Risk
- Manufacturer to carrier. Pickup delays, loading practices, and shipper conditioning.
- Airport cargo handling. Waiting on ramps or in non-temperature-controlled areas between flights.
- Port and drayage. Reefer containers that depend on power at every stop, a concern covered in IoT at Port Newark and Elizabeth.
- Warehouse and cross-dock transfer. Dock doors left open and pallets staged outside refrigerated zones, which warehouse tracking in real-time asset tracking for New Jersey warehouses helps to expose.
- Final delivery. Receivers who are not ready, closed offices, and refrigerators with no monitoring.
Visibility across these handoffs is the idea behind connected freight links between ports and warehouses and fleet and cold chain tracking in the port corridor.
Alert Design That People Respond To
A tracker that sends hundreds of alerts is worse than none. Define alert and action levels, set delays so short door openings do not trigger action, and route alerts to named people with backup. Write a response playbook for each type of event: temperature rising in transit, a shipment delayed at a hub, a power loss in a cold room. Include phone numbers, decision authority, and instructions for documenting the event. Test the process with drills.
A Composite Example
Consider a specialty distributor in central New Jersey that ships temperature-sensitive injectables to clinics. It has used simple loggers, and once or twice a month a clinic reports a reading out of range, after the product has already been used or discarded. The distributor moves its highest-value lanes to real-time trackers with temperature, location, and door alerts. In the first season, a tracker flags a shipment sitting at a carrier hub on a hot afternoon. A dispatcher calls the hub, the package is moved to refrigeration within minutes, and the product is delivered within range. The records also help the distributor negotiate service levels with carriers. This scenario is illustrative, not a report on a specific company.
Cell and Gene Therapy: A Different Kind of Cold Chain
Advanced therapies built from a patient's own cells raise stakes beyond temperature. Material often travels at very low temperatures in liquid nitrogen dry shippers, and each shipment is for a single patient, so a lost or mixed-up container cannot be replaced from stock. Monitoring must cover temperature, the status of the shipper's cryogenic charge, location, and chain of identity, meaning an unbroken record that the right material reached the right patient. Tracking events such as handoff scans and shipper opening, along with environmental data, builds that record. New Jersey's role in this field is growing as manufacturers and logistics partners expand, and carriers who can show integrated tracking and clean handoffs have an advantage.
Last Mile: Hospitals, Clinics, and Pharmacies
The final step is often the weakest. Receivers may not know a shipment is arriving, may leave it on a counter, or may store it in a refrigerator that is not monitored. Provide receiving instructions with every shipment, use alerts that tell the receiver when to expect delivery, and where possible ask for confirmation that product has been placed in controlled storage. Pharmacies and clinics that monitor refrigerators with connected sensors close the loop. The same principles apply as in connected care and remote monitoring, where the equipment inside a hospital or clinic is part of the care chain.
Cost and Return
Costs include devices, replacement and return logistics, software, and staff time. Return comes from avoided product loss, fewer shipments quarantined without data to support a decision, fewer replacement shipments and patient delays, and stronger evidence in carrier disputes and inspections. For high-value products, a single avoided loss may cover the cost of a season's monitoring. Start by measuring what excursions currently cost, including investigation time, then decide where real-time monitoring adds the most value.
Data Sharing Between Partners
Cold chain data is useful only if the right people can see it. Manufacturers need shipment and excursion data from carriers and distributors, and carriers need clear instructions about what to do when alerts occur. Agree in contracts on what data is shared, how fast, in what format, and who can act on it. Open interfaces and standard data formats make it easier to combine data from different trackers into one view. Where a partner will not share data, that gap should be treated as a risk and assessed like any other supplier weakness.
Metrics to Track
- Excursions per thousand shipments, by lane, carrier, and season.
- Product value lost or quarantined because of excursions.
- Time from alert to response and to resolution.
- Share of shipments with complete, usable temperature data.
- Time spent on excursion investigations.
Common Mistakes
Using the same sensor placement and settings for every product is the first. Others are ignoring freezing risk for refrigerated products, forgetting calibration of devices, not testing shippers in New Jersey winter and summer conditions, failing to define who answers an alert, and treating monitoring as a purchase instead of a process. Manufacturers should connect cold chain data with the quality system, and carriers should be contractually required to share it. The broader picture, from plant to patient, is explored in IoT across the New Jersey pharmaceutical industry and Pharma 4.0 and IoT.
